Table 4

The percentage distribution of p16Ink4a immunohistochemical staining in the CaexPA group in reference to survival rate

p16Ink4a expression in CaexPAPositive, %Borderline, %No expression, %
Survival, years
 310090.0100
 590.5673.6475
 1060.3722.200.0
  • CaexPA, carcinoma ex pleomorphic adenoma.